切换导航
关闭
  • 菜单
  • Setting

Hygromycin B

潮霉素B
Catalog No.
A2515
选择性抗生素
组合的产品项目
规格价格库存 数量
200mg
¥ 454.00
现货
500mg
¥ 727.00
现货

电话: 021-55669583

邮箱: sales@apexbio.cn

全球经销商

A

背景

Hygromycin B是一种选择性抗生素,用于治疗和预防细菌感染。

Hygromycin B是一种抗生素,对大多数细菌、真菌和高等真核细胞有效。Hygromycin B具有30S亚基,含有单个结合位点,这与它的单相作用一致。该结合位点位于螺旋的大沟内,具有高度序列特异性。Hygromycin B通过抑制延长过程中的易位步骤和促使70S核糖体mRNA的错误翻译,抑制蛋白质合成[1]。在70S核糖体中,Hygromycin B选择性抑制核糖体ATP酶(RbbA)的活性,将RbbA从70S核糖体释放,RbbA增强16S rRNA开关螺旋区域A889和G890的反应性。另外,Hygromycin B可以保护解码区域的G1494和A1408。

参考文献:
[1]. Brodersen DE, Clemons WM Jr, Carter AP, et al. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell, 2000, 103(7): 1143-1154.
[2]. Ganoza MC, Kiel MC. A ribosomal ATPase is a target for hygromycin B inhibition on Escherichia coli ribosomes. Antimicrob Agents Chemother, 2001, 45(10): 2813-2819.

化学属性

Physical AppearanceA solid
StorageStore at -20°C
M.Wt527.5
Cas No.31282-04-9
FormulaC20H37N3O13
Solubility≥26.38 mg/mL in H2O; ≥5.35 mg/mL in EtOH; ≥9.14 mg/mL in DMSO
Chemical Name(3'R,3aS,4S,4'R,5'R,6R,6'R,7S,7aS)-4-[(1R,2S,3R,5S,6R)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6'-[(1S)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol
SDFDownload SDF
Canonical SMILESCNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N
运输条件 蓝冰运输或根据您的需求运输。
一般建议不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

试验操作

Cell experiment:[1]

Cell lines

Mouse L cells

Reaction Conditions

200 μg/ml hygromycin B for 2 ~ 6 weeks

Applications

Hygromycin B was used for resistance selection in mouse L cells transfected with Escherichia coli genes coding for resistance to the aminocyclitol antibiotics hygromycin B.

Animal experiment:[2]

Animal models

Four-week-old BALB/c mice susceptible to MHV-A59 infection

Dosage form

0 ~ 10 μmol/kg

Intraperitoneal (i.p.) injection

Applications

A single injection of hygromycin B reduced the number of lesions in the livers of MHV-A59-inoculated mice. Higher doses of the drug appeared to be slightly more effective at reducing virus-induced lesions.

Note

The technical data provided above is for reference only.

 

References:

1. Santerre RF, Allen NE, Hobbs JN Jr, et al. Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells. Gene, 1984, 30(1-3): 147-156.

2. Macintyre G, Curry B, Wong F, et al. Hygromycin B therapy of a murine coronaviral hepatitis. Antimicrobial Agents and Chemotherapy, 1991, 35(10): 2125-2127.

 

质量控制